Controlled sustained release tablets containing bupropion

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5427798
SERIAL NO

08105447

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A controlled sustained release tablet having at least one year shelf life and containing bupropion hydrochloride, hydroxypropyl methylcellulose and cysteine hydrochloride or glycine hydrochloride with the tablet having a surface area to volume ratio to effectively control bupropion hydrochloride release in the body.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SMITHKLINE BEECHAM CORPORATION A PENNSYLVANIA CORPORATIONONE FRANKLIN PLAZA PHILADELPHIA PA 19102

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bass, Jr William L Farmville, NC 1 140
Ludwig, Jennie Sue G Greenville, NC 1 140
Sutton, Jr Joel E Greenville, NC 4 380

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation